SOW
RLAY icon

State of Wyoming’s Relay Therapeutics RLAY Stock Holding History

State of Wyoming’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
+11,618
New +$169K 0.02% 955
2022
Q3 		– Sell
-304
Closed -$5K – 1874
2022
Q2 		$5K Buy
+304
New +$6.51K ﹤0.01% 1727

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

State of Wyoming's RLAY Position: Q2 2026 in Review

State of Wyoming opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 11,618 shares worth $217K. The stake represents 0.02% of the portfolio and ranks #955 among its holdings. This is a return to the name: State of Wyoming previously reported a position in RLAY as recently as Q2 2022.

State of Wyoming first reported a position in RLAY in Q2 2022 and has held it in 2 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • State of Wyoming held 11,618 shares of Relay Therapeutics worth $217K as of Q2 2026.
  • Relay Therapeutics was a new State of Wyoming position in Q2 2026.
  • Relay Therapeutics made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #955 holding.
  • State of Wyoming first reported a position in Relay Therapeutics in Q2 2022 and has held it in 2 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.